Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non‐alcoholic fatty liver disease
Open Access
- 20 September 2006
- journal article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 24 (8), 1215-1222
- https://doi.org/10.1111/j.1365-2036.2006.03112.x
Abstract
Summary Background Non‐alcoholic fatty liver disease is prevalent in affluent countries and is strongly associated with metabolic syndrome. Aim To study the prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non‐alcoholic fatty liver disease. Methods 73 consecutive patients with biopsy‐proven non‐alcoholic fatty liver disease and no history of diabetes underwent comprehensive metabolic screening. Diagnosis of diabetes and impaired glucose regulation was based on the 2006 American Diabetes Association criteria. Results The prevalence of undiagnosed diabetes and impaired glucose tolerance in non‐alcoholic fatty liver disease patients was 33% and 29%, respectively. Among patients with 2‐h plasma glucose above 7.8 mm, 47% had normal fasting glucose (below 5.6 mm). Impaired glucose tolerance was more common in patients with non‐alcoholic steatohepatitis than those with simple hepatic steatosis (P = 0.036), and 2‐h plasma glucose correlated with fibrosis stage (Spearman coefficient: 0.25, P = 0.046). In a binary logistic regression analysis, high fasting glucose and low high‐density lipoprotein cholesterol were independent factors associated with diabetes. Nevertheless, if oral glucose tolerance test was only performed in non‐alcoholic fatty liver disease patients with impaired fasting glucose, 20.8% of diabetes cases would be missed. Conclusions Isolated postchallenge hyperglycaemia is common among Chinese non‐alcoholic fatty liver disease patients without history of diabetes. It is associated with histological severe disease, and cannot be accurately predicted by any fasting glucose cut‐off.Keywords
This publication has 36 references indexed in Scilit:
- Metabolic and Adipokine Profile of Chinese Patients With Nonalcoholic Fatty Liver DiseaseClinical Gastroenterology and Hepatology, 2006
- Prevalence of non‐alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adultsDiabetic Medicine, 2005
- Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver diseaseHepatology, 2005
- Prevalence of and risk factors for fatty liver in a general population of Shanghai, ChinaJournal of Hepatology, 2005
- The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsiesJournal of Hepatology, 2004
- Natural history of nonalcoholic steathepatitis: A longitudinal study of repeat liver biopsiesHepatology, 2004
- Clinical and histological features of non‐alcoholic fatty liver disease in Hong Kong ChineseAlimentary Pharmacology & Therapeutics, 2004
- Association of Nonalcoholic Fatty Liver Disease With Insulin ResistanceJournal of Clinical Gastroenterology, 2003
- Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic SyndromeHepatology, 2003
- NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndromeHepatology, 2002